News

Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable ...
GH Research (NASDAQ:GHRS) is one of the best-performing NASDAQ stocks according to analysts. On June 20, GH Research ...
Psilocybin, the active compound derived from psychedelic mushrooms, significantly delayed cellular aging and extended ...
What if the way out of depression isn’t doing more, but doing less, on purpose? Learn how small, quiet steps can help you ...
Depression is everywhere these days, but mental health professionals are not. Some alternative treatments that could help are ...
Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...
A phase 2 trial shows that a single dose of psilocybin provides lasting relief from symptoms of depression and anxiety. New ...
BSA Behavioral Health announced it is expanding its mental health services to include Spravato (esketamine) nasal spray, for ...
Deep transcranial magnetic stimulation was safe and effective in treating adolescents and young adults with major depressive ...
Earlier identification is also of interest due to the possibility that earlier intervention may be more effective with more ...
Medical University of South Carolina (MUSC) is working to make treatment for depression more accessible with its new mobile ...